Metraipolis › archive › dc_730dd3c6355f
ZSTK3744, a Novel Aryl Hydrocarbon Receptor Agonist, Exhibits Efficacy against Chemotherapy-Resistant Triple-Negative Breast Cancer — Europe PMC PMID:41628058
- Source
- Europe PMC (en)
- Original
- https://europepmc.org/article/MED/41628058
- DOI
- 10.1158/2767-9764.crc-25-0119
- License (as archived)
- solo-consultazione
- Archived
- 2026-11-06T09:12:05.400Z
- SHA-256 of the archived text
5b3a98753787ef920d8214653ac2832a2c1c36202b52fced9a07aebad8055efa- Stable URL of this page
https://metraipolis.com/documento/dc_730dd3c6355f
How to cite
ZSTK3744, a Novel Aryl Hydrocarbon Receptor Agonist, Exhibits Efficacy against Chemotherapy-Resistant Triple-Negative Breast Cancer — Europe PMC PMID:41628058 — Europe PMC (en), https://europepmc.org/article/MED/41628058 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_730dd3c6355f (Metraipolis archive dc_730dd3c6355f, sha256 5b3a98753787ef920d8214653ac2832a2c1c36202b52fced9a07aebad8055efa)
BibTeX
@misc{dc730dd3c6355f,
title = {ZSTK3744, a Novel Aryl Hydrocarbon Receptor Agonist, Exhibits Efficacy against Chemotherapy-Resistant Triple-Negative Breast Cancer — Europe PMC PMID:41628058},
howpublished = {Europe PMC (en)},
url = {https://europepmc.org/article/MED/41628058},
note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_730dd3c6355f; sha256 5b3a98753787ef920d8214653ac2832a2c1c36202b52fced9a07aebad8055efa},
year = {2026}
}Archived text
The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/41628058. Agents can read the archived copy with the MCP tool read_document.